Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Br J Clin Pharmacol ; 31(1): 33-9, 1991 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2015168

RESUMO

1. The effects of pinacidil (25 mg, sustained release formulation) a) on systemic (arterial pressure, cardiac output) and regional (brachial and carotid arteries' diameters and flows) haemodynamics (pulsed Doppler techniques), b) on sympathetic (plasma noradrenaline) and renin-angiotensin (plasma renin activity) systems, and c) on atrial natriuretic factor have been investigated and compared with those of a placebo during the 12 h period following oral administration in a randomized, double-blind and cross-over study performed in six healthy volunteers. Simultaneously, the plasma levels of pinacidil and of its active metabolite, pinacidil N-oxide, were determined. 2. As compared with placebo, pinacidil decreased systemic vascular resistance and arterial blood pressure but cardiac output was not modified. 3. Pinacidil significantly increased brachial and carotid arteries' diameters (by 7 and 8% respectively) and flows (by 60 and 17% respectively) and decreased forearm vascular resistance (by 43%). Thus, pinacidil dilates both large and small arteries, increases large vessels' compliance and redistributes blood flow towards the muscular vascular bed. These effects peaked at 4 h and their duration at the brachial level was 8 h. 4. Pinacidil administration resulted in a stimulation of both sympathetic (increases in heart rate and plasma noradrenaline) and renin-angiotensin systems, and induced a transient increase in atrial natriuretic factor. 5. The duration of pinacidil haemodynamic effects at the brachial level is consistent with the pharmacokinetic data which show that pinacidil and pinacidil N-oxide plasma levels almost plateaued between 3 and 8, and 2 and 8 h respectively after oral administration of the sustained release formulation used.


Assuntos
Guanidinas/farmacologia , Vasodilatação/efeitos dos fármacos , Adulto , Artérias/efeitos dos fármacos , Guanidinas/efeitos adversos , Guanidinas/farmacocinética , Hemodinâmica/efeitos dos fármacos , Hormônios/sangue , Humanos , Pinacidil , Fluxo Sanguíneo Regional/efeitos dos fármacos , Sistema Renina-Angiotensina/efeitos dos fármacos , Sistema Nervoso Simpático/efeitos dos fármacos
3.
Eur J Clin Pharmacol ; 41(4): 329-34, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1804649

RESUMO

The systemic and regional haemodynamic and cardiac effects of two oral doses (100 and 300 mg) of a new sulphone-indolizine calcium antagonist SR 33,557 (SR) and a placebo were non invasively investigated in a double-blind, cross-over study in 6 healthy male volunteers. Arterial pressure, heart rate, cardiac output, brachial and carotid artery diameters and flows and PR and QT intervals were studied. Stroke volume, total peripheral and forearm vascular resistance, regional cardiac output distribution indices and corrected QT intervals were calculated. SR did not produce any significant modification in systemic haemodynamics, although arterial pressure and cardiac output tended to decrease slightly after 300 mg. In contrast, at the regional level, ST produced strong vasodilatation and significantly increased brachial and carotid blood flow. SR-induced vasodilation affected only the arterioles, as shown by a significant decrease in forearm vascular resistance, but not the large arteries, as shown by lack of change in the brachial and carotid artery diameters. SR-induced vasodilation preferentially affected the brachial rather than the carotid vascular bed, resulting in a redistribution of cardiac output towards the musculo-cutaneous territories. SR caused a marked and long-lasting decrease in heart rate, but it did not affect the auriculo-ventricular conduction time.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Hemodinâmica/efeitos dos fármacos , Indolizinas/farmacologia , Fenetilaminas/farmacologia , Adulto , Pressão Sanguínea/efeitos dos fármacos , Artéria Braquial/fisiologia , Débito Cardíaco/efeitos dos fármacos , Artérias Carótidas/fisiologia , Método Duplo-Cego , Ecocardiografia Doppler/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Masculino , Fluxo Sanguíneo Regional/efeitos dos fármacos , Volume Sistólico/efeitos dos fármacos , Resistência Vascular/efeitos dos fármacos
4.
Int J Vitam Nutr Res ; 56(3): 269-73, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3781751

RESUMO

When rats consumed a well-balanced diet containing 30% lactose or 30% glucose-galactose mixture, the biological composition of the lens was more disturbed in female: the leak of inositol and the accumulation of galactitol were higher than in the male.


Assuntos
Humor Aquoso/metabolismo , Galactose/metabolismo , Cristalino/metabolismo , Animais , Catarata/etiologia , Carboidratos da Dieta/farmacologia , Feminino , Galactitol/metabolismo , Galactose/farmacologia , Galactosemias/etiologia , Glucose/farmacologia , Lactose/farmacologia , Masculino , Ratos
5.
Int J Vitam Nutr Res ; 56(3): 303-6, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3781757

RESUMO

When rats consumed a well-balanced diet containing 30% lactose or 30% glucose-galactose mixture, some differences of metabolic utilization arose between males and females. With lactose, the urinary excretion of lactose, galactose and galactitol was higher in females. With the glucose-galactose mixture, galactosury and galactitolury in males and females increased and were similar; but galactosaemia and galactitolaemia were more important in females.


Assuntos
Galactose/metabolismo , Animais , Carboidratos da Dieta/administração & dosagem , Feminino , Galactitol/metabolismo , Galactose/administração & dosagem , Glucose/administração & dosagem , Lactose/administração & dosagem , Masculino , Ratos , Ratos Endogâmicos , Fatores Sexuais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...